Matches in SemOpenAlex for { <https://semopenalex.org/work/W2800657124> ?p ?o ?g. }
- W2800657124 endingPage "2223" @default.
- W2800657124 startingPage "2216" @default.
- W2800657124 abstract "Melanoma, a melanocyte origin neoplasm, is the most lethal type of skin cancer, and incidence is increasing. Several familial and somatic mutations have been identified in the gene encoding the melanocyte lineage master regulator, MITF; however, the neoplastic mechanisms of these mutant MITF variants are mostly unknown. Here, by performing unbiased analysis of the transcriptomes in cells expressing mutant MITF, we identified calcium-binding protein S100A4 as a downstream target of MITF-E87R. By using wild-type and mutant MITF melanoma lines, we found that both endogenous wild-type and MITF-E87R variants occupy the S100A4 promoter. Remarkably, whereas wild-type MITF represses S100A4 expression, MITF-E87R activates its transcription. The opposite effects of wild-type and mutant MITF result in opposing cellular phenotypes, because MITF-E87R via S100A4 enhanced invasion and reduced adhesion in contrast to wild-type MITF activity. Finally, we found that melanoma patients with altered S100A4 expression have poor prognosis. These data show that a change in MITF transcriptional activity from repression to activation of S100A4 that results from a point mutation in MITF alters melanoma invasive ability. These data suggest new opportunities for diagnosis and treatment of metastatic melanoma. Melanoma, a melanocyte origin neoplasm, is the most lethal type of skin cancer, and incidence is increasing. Several familial and somatic mutations have been identified in the gene encoding the melanocyte lineage master regulator, MITF; however, the neoplastic mechanisms of these mutant MITF variants are mostly unknown. Here, by performing unbiased analysis of the transcriptomes in cells expressing mutant MITF, we identified calcium-binding protein S100A4 as a downstream target of MITF-E87R. By using wild-type and mutant MITF melanoma lines, we found that both endogenous wild-type and MITF-E87R variants occupy the S100A4 promoter. Remarkably, whereas wild-type MITF represses S100A4 expression, MITF-E87R activates its transcription. The opposite effects of wild-type and mutant MITF result in opposing cellular phenotypes, because MITF-E87R via S100A4 enhanced invasion and reduced adhesion in contrast to wild-type MITF activity. Finally, we found that melanoma patients with altered S100A4 expression have poor prognosis. These data show that a change in MITF transcriptional activity from repression to activation of S100A4 that results from a point mutation in MITF alters melanoma invasive ability. These data suggest new opportunities for diagnosis and treatment of metastatic melanoma." @default.
- W2800657124 created "2018-05-17" @default.
- W2800657124 creator A5007738169 @default.
- W2800657124 creator A5010191405 @default.
- W2800657124 creator A5016180503 @default.
- W2800657124 creator A5021648941 @default.
- W2800657124 creator A5040764617 @default.
- W2800657124 creator A5042139239 @default.
- W2800657124 creator A5042938981 @default.
- W2800657124 creator A5053091431 @default.
- W2800657124 creator A5063063023 @default.
- W2800657124 creator A5069537648 @default.
- W2800657124 creator A5069853824 @default.
- W2800657124 creator A5072487720 @default.
- W2800657124 creator A5080567933 @default.
- W2800657124 creator A5081297649 @default.
- W2800657124 creator A5084331574 @default.
- W2800657124 creator A5088449958 @default.
- W2800657124 creator A5088841645 @default.
- W2800657124 date "2018-10-01" @default.
- W2800657124 modified "2023-09-27" @default.
- W2800657124 title "Mutated MITF-E87R in Melanoma Enhances Tumor Progression via S100A4" @default.
- W2800657124 cites W109896574 @default.
- W2800657124 cites W1590243782 @default.
- W2800657124 cites W1651595593 @default.
- W2800657124 cites W1963091570 @default.
- W2800657124 cites W1966719726 @default.
- W2800657124 cites W1967662608 @default.
- W2800657124 cites W1967834264 @default.
- W2800657124 cites W1982635732 @default.
- W2800657124 cites W2010243889 @default.
- W2800657124 cites W2013859796 @default.
- W2800657124 cites W2015009944 @default.
- W2800657124 cites W2033961695 @default.
- W2800657124 cites W2062767635 @default.
- W2800657124 cites W2065030089 @default.
- W2800657124 cites W2067937212 @default.
- W2800657124 cites W2068050272 @default.
- W2800657124 cites W2098763910 @default.
- W2800657124 cites W2102927263 @default.
- W2800657124 cites W2104467529 @default.
- W2800657124 cites W2104503053 @default.
- W2800657124 cites W2107513374 @default.
- W2800657124 cites W2110466396 @default.
- W2800657124 cites W2113271533 @default.
- W2800657124 cites W2114843025 @default.
- W2800657124 cites W2125842849 @default.
- W2800657124 cites W2128096701 @default.
- W2800657124 cites W2149441684 @default.
- W2800657124 cites W2153938645 @default.
- W2800657124 cites W2154833452 @default.
- W2800657124 cites W2319190863 @default.
- W2800657124 cites W2510540705 @default.
- W2800657124 cites W2620797288 @default.
- W2800657124 cites W4250635458 @default.
- W2800657124 doi "https://doi.org/10.1016/j.jid.2018.03.1524" @default.
- W2800657124 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29679610" @default.
- W2800657124 hasPublicationYear "2018" @default.
- W2800657124 type Work @default.
- W2800657124 sameAs 2800657124 @default.
- W2800657124 citedByCount "7" @default.
- W2800657124 countsByYear W28006571242019 @default.
- W2800657124 countsByYear W28006571242020 @default.
- W2800657124 countsByYear W28006571242021 @default.
- W2800657124 countsByYear W28006571242022 @default.
- W2800657124 countsByYear W28006571242023 @default.
- W2800657124 crossrefType "journal-article" @default.
- W2800657124 hasAuthorship W2800657124A5007738169 @default.
- W2800657124 hasAuthorship W2800657124A5010191405 @default.
- W2800657124 hasAuthorship W2800657124A5016180503 @default.
- W2800657124 hasAuthorship W2800657124A5021648941 @default.
- W2800657124 hasAuthorship W2800657124A5040764617 @default.
- W2800657124 hasAuthorship W2800657124A5042139239 @default.
- W2800657124 hasAuthorship W2800657124A5042938981 @default.
- W2800657124 hasAuthorship W2800657124A5053091431 @default.
- W2800657124 hasAuthorship W2800657124A5063063023 @default.
- W2800657124 hasAuthorship W2800657124A5069537648 @default.
- W2800657124 hasAuthorship W2800657124A5069853824 @default.
- W2800657124 hasAuthorship W2800657124A5072487720 @default.
- W2800657124 hasAuthorship W2800657124A5080567933 @default.
- W2800657124 hasAuthorship W2800657124A5081297649 @default.
- W2800657124 hasAuthorship W2800657124A5084331574 @default.
- W2800657124 hasAuthorship W2800657124A5088449958 @default.
- W2800657124 hasAuthorship W2800657124A5088841645 @default.
- W2800657124 hasBestOaLocation W28006571241 @default.
- W2800657124 hasConcept C104317684 @default.
- W2800657124 hasConcept C143065580 @default.
- W2800657124 hasConcept C177504595 @default.
- W2800657124 hasConcept C207583985 @default.
- W2800657124 hasConcept C2777658100 @default.
- W2800657124 hasConcept C2779769559 @default.
- W2800657124 hasConcept C502942594 @default.
- W2800657124 hasConcept C54355233 @default.
- W2800657124 hasConcept C86339819 @default.
- W2800657124 hasConcept C86803240 @default.
- W2800657124 hasConceptScore W2800657124C104317684 @default.
- W2800657124 hasConceptScore W2800657124C143065580 @default.
- W2800657124 hasConceptScore W2800657124C177504595 @default.